Laureate to Produce Antibody for Lpath

August 31, 2006
BioPharm International Editors

Lpath, Inc. (San Diego, CA, www.lpath.com) and Laureate Pharma, Inc. (Princeton, NJ, www.laureatepharma.com) have entered into an agreement for Laureate to manufacture Lpath's recombinant humanized monoclonal antibody, "Sphingomab," against bioactive lipids.

Lpath, Inc. (San Diego, CA, www.lpath.com) and Laureate Pharma, Inc. (Princeton, NJ, www.laureatepharma.com) have entered into an agreement for Laureate to manufacture Lpath’s recombinant humanized monoclonal antibody, “Sphingomab,” against bioactive lipids. Laureate will provide cell line development, optimization, and upstream and downstream process development, followed by cGMP manufacture for the product for use in clinical trials.

Related Content:

News